4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-013751
Options or other derivatives
- Chief Executive Officer acquired 142,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2017-02-21 | Grant or award · Stock option (right to buy) | +142,900 | 142,900 | D | ||
Loading xslF345X03/doc4.xml…